FIELD OF THE INVENTION

The invention is in the field of point-of-care analysis of Cannabis, Cannabis-based products and other products.

BACKROUND OF THE INVENTION

Medicinal Cannabis is a broad term for a variety of Cannabis-based medicines that are widely used for the management and treatment of a number of disorders. Cannabis has been show to help patents of epilepsy and Parkinson disorder among many other disorders. Cannabis also has potential to help patent suffering from chronic pain and cancer by managing symptoms or the side effects of other treatments, such as chemotherapy.

Cannabinoids are a diverse class of chemical compounds that act on the cannabinoid receptors. Phyto-cannabinoids are cannabinoids found in plants, mainly found in the Cannabis genus. Over 110 cannabinoids have been identified in Cannabis. The different cannabinoids exhibit different pharmacological and chemical characteristics. The ration of the different cannabinoids in a product can affect the potential use of medicinal Cannabis are its therapeutic target.

US application 20170059536A1 describes a Cannabis analysis system including a solvent input port configured to receive a flow of a solvent, a sample input port configured to receive a chemical mixture including a sample, a pump configured to move the solvent and chemical mixture, an extraction cartridge coupled to the pump and configured to separate a combination of the chemical mixture and the flow of the solvent into two or more partially-separated chemical components, a spectroscopy cell configured to generate a chromatogram including two or more overlapping absorption peaks corresponding to the two or more partially-separated chemical components, and a controller configured to determine a chemical concentration of each partially-separated chemical component of the two or more partially-separated chemical components.

US application 201701991681A1 describes systems and methods of evaluating Cannabis and cannabinoid products for public safety, quality control and quality assurance purposes for research and public use purposes. Embodiments of the invention facilitate suppliers and consumers of a Cannabis and/or cannabinoid product to evaluate the origin, efficacy, potency, and quality of the product. Embodiments of the invention also include Cannabis processing center where samples of the products are analyzed for research studies to test and set parameters for third parties. Embodiments of the invention include, for example, analyzing Cannabis products to determine quality and quantity of desired components and undesired components, determining concentrations of cannabinoids in the product, and comparing measures of components in the product against regulations. Embodiments of the invention further include, for example, an online testing facility for determine whether Cannabis products meet a plurality of regulations or guidelines.

There exists a long felt need for a point-of-care method for the analysis of a Cannabis product for patents.

SUMMARY

A system for analyzing a Cannabis product 10, comprising:

- a. at least one detecting unit 11 22; the unit comprising
  - i. at least one detector 92; and
  - ii. at least one detection/sensor/sensing source;
  - iii. a computer readable medium (CRM) , the CRM configured to process the detection results;
- b. a processing unit 12 23, the unit configured to read the detection results;
- c. a communication unit 13 24, the unit configured to transmit the results;
- d. an analysis database 15 26; and
- an analysis unit 14 25, the unit configured to analyses the product results and compare the results to the database;
- wherein the system provides a report, the report disclosing the quality of the sample.

It is another object of the current invention to disclose the system as defined above, wherein the detector 11 22 is selected from a group of technologies consisting of chemical detectors, spectroscopic detectors, electrochemical, luminescent, fluorescent, optical, polymer, hydrogels, surface acoustic wave (SAW) electronic-nose sensors, as immunological (antibody), enzyme-linked immunosorbent assay (ELISA), enzymatic biosensor microbial biosensors, fiber optic biosensors, quartz crystal microbalance (QCM) and electromagnetic QCM (EQCM). It is another object of the current invention to disclose the system as defined in any of the above, wherein the detector is configured to detect at least one environmental condition.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the conditions are selected from a group consisting of temperate and humidity.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the detector is configured to analyze volatile compounds.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the system additionally comprises a sample holder.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the holder is configured to position a solid sample or a liquid sample.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the holder additionally comprises a heating unit.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the heating unit is selected from a group consisting of Infrared light, heating coil, electric element.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the communication 13 unit is configured to communicate using wired or wireless technologies selected from a group consisting of, but not limited to, wireless local area networks (WLAN), Low-Power Wide-Area Networks (LPWAN), wireless wide area network (WWAN), wireless sensor networks, Bluetooth, cellular networks, and any combination of.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the database 15 26 comprises at least one of the following:

- a. database of medicinal Cannabis detection results/analysis;
- b. database of cannabinoid analysis/results;
- c. database of impurities detection results/analysis.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the impurities are selected from a group consisting of pesticides, insecticides, toxins, pesticides, fungicides, Biological contaminants (fungi).

It is another object of the current invention to disclose the system as defined in any of the above, wherein the system additional comprises a display for presenting the analysis results.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the system is powered by an internal electricity source, the source being a battery.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the analysis unit 14 25 is configured to communicate the result to another device or system.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the analysis unit is configured to communicate using wired or wireless technologies selected from a group consisting of, but not limited to, wireless local area networks (WLAN), Low-Power Wide-Area Networks (LPWAN), wireless wide area network (WWAN), wireless sensor networks, Bluetooth, cellular networks, and any combination of.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the analysis unit is configured to communicate using computer-mediated communication (CMC), the CMC selected from a group consisting of email, text message, and web-based application.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the communication is by an application installed on a mobile device.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the analysis unit is configured to mine a database for product analysis.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the sample analysis is conducted by a function selected from a group consisting of an agent, a decision tree, an algorithm and any combination thereof.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the agent is configured to analyze the data, the data selected from a group consisting of sample data, detection data and any combination thereof.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the agent is configured to detect the samples tag, classification, sample data, detection data and any combination thereof.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the tag and/or classification is selected from a group consisting of chemical composition,

It is another object of the current invention to disclose the system as defined in any of the above, wherein the analysis is a function determined by employing machine learning.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the system additionally comprises a reporting unit 27, the unit configured to:

- a. generate an analysis report;
- b. transmit analysis report to a pharmacovigilance unit 28;
- c. communicate Cannabis analysis results.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the system additionally comprises a pharmacovigilance unit 28.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the pharmacovigilance unit 28 is configured to:

- a. receive health information from the patent;
- b. receive health information for a healthcare person;
- c. receive health information for a healthcare system;
- d. receive Cannabis analysis results from reporting unit;
- e. communicate pharmacovigilance data to the reporting unit;

It is another object of the current invention to disclose the system as defined in any of the above, wherein the pharmacovigilance unit is configured to receive health information and to present a questionnaire to the patent or patent care giver, the questionnaire comprising questions regarding patent health, treatment effect, and additional treatments.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the health information comprises long term effects of treatments, the effects including adverse drug reactions, drug-drug interactions, side effects, benefits, effectiveness, and efficacy.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the external person or system is a healthcare person, a patents group or a regulatory body.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the system additionally comprises a product unit 21, configured to input information about the product.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the product information is selected from a group consisting of the product batch, manufacturing date, source, producer, manufacturer, and storage and transport conditions.

It is the object of the current invention to disclose a method analyzing a Cannabis product 100, comprising steps of

- a. receiving a Cannabis product 101;
- b. obtaining a Cannabis sample 102;
- c. providing an detection unit;
- d. analyzing the sample with the detection unit 103;
- e. processing results 104;
- f. transferring results to the analysis unit 105;
- g. analyzing results 106;
- h. retrieving data from a database 107; and
- i. generating a report of the analysis 108;
  - wherein the report comprises an analysis of the Cannabis product.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the method additionally comprises a step of heating the sample.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the step of heating the sample is conducted by using a technology selected from a group consisting of Infrared light, heating coil, and electric heater.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the method additionally comprises a step of evaporating volatile compounds of the sample.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the step of detecting the composition of the sample is conducted by a technology selected from a group consisting of chemical detectors, spectroscopic detectors, electrochemical, luminescent, fluorescent, optical, polymer, hydrogels, surface acoustic wave (SAW) electronic-nose sensors, as immunological (antibody), enzyme-linked immunosorbent assay (ELISA), enzymatic biosensor microbial biosensors and fiber optic biosensors

It is another object of the current invention to disclose the method as defined in any of the above, wherein the method additionally comprises a step of retrieving data from a database 107, the database comprising:

- a. database of medicinal Cannabis detection results/analysis;
- b. database of cannabinoid detection results/analysis; and
- c. database of impurities detection results/analysis

It is another object of the current invention to disclose the method as defined in any of the above, wherein the step of retrieving data from the impurities database is selected from a group consisting of pesticides, insecticides, toxins, pesticides, fungicides, Biological contaminants (fungi).

It is another object of the current invention to disclose the method as defined in any of the above, wherein the analysis comprises stages of:

- a. identifying the chemical content of the identified product;
- b. identifying Cannabis constituents; and
- c. identifying contaminants in the sample;

It is another object of the current invention to disclose the method as defined in any of the above, wherein the sample analysis is conducted by a function selected from a group consisting of an agent, a decision tree, an algorithm and any combination thereof.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the function is configured to analyze the data, the data selected from a group consisting of sample data, detection data and any combination thereof.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the function is configured to detect the samples tag, classification, detection data and any combination thereof.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the tag and/or classification is selected from a group consisting of chemical composition,

It is another object of the current invention to disclose the method as defined in any of the above, wherein the analysis function is determined by employing machine learning.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the determining of the function comprises step of;

- a. loading sample data to the the database;
- b. checking the tagging of the data;
- c. if sample is tagged, adding the sample for non-supervised machine learning training;
- d. filtering and clustering the sample data;
- e. sorting the sample data in multi-level hierarchy;
- f. importing of the user medical data;
- g. analyzing the relation;
- h. analyzing the sample data with relevancy to the user; and
- i. storing of analysis in database with recommendation.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the determining of the function comprises step of;

- a. loading sample data to the the database;
- b. checking the tagging of the data;
- c. if sample is not tagged, adding the sample for supervised machine learning training;
- d. identifying features and identifications of the sample;
- e. improving the analysis function;
- f. storing the function in the database; and
- g. comparing the new function to previous function;
- h. replacing previous function, if new function is better.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the method additionally comprises a step of updating a Pharmacovigilance unit 109.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the step of updating the Pharmacovigilance unit comprises steps of:

- a. inputting healthcare results;
- b. inputting information from a healthcare professional;
- c. questioning the patent.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the method additionally comprises a step of updating the treatment of the patent 111.

It is another object of the current invention to disclose the method as defined in any of the above, wherein the step of updating the treatment 111 comprises steps of:

- a. updating Cannabis product;
- b. updating Cannabis dose;
- c. updating treatment schedule;

It is the object of the current invention to disclose a system for analyzing a Tabaco product 10, comprising:

- a. At least one detecting unit 11 22; the unit comprising
  - i. at least one detector 92; and
  - ii. at least one detection/sensor/sensing source;
  - iii. a computer readable medium (CRM), the CRM configured to process the detection results;
- b. a processing unit 12 23, the unit configured to read the detection results;
- c. a communication unit 13 24, the unit configured to transmit the results;
- d. an analysis database 15 26; and
- e. an analysis unit 14 25, the unit configured to analyses the product results and compare the results to the database;
- wherein the system provides a report, the report disclosing the quality of the sample.

It is another object of the current invention to disclose the system as defined in any of the above, wherein the detector 11 22 is selected from a group of technologies consisting of chemical detectors, spectroscopic detectors, electrochemical, luminescent, fluorescent, optical, polymer, hydrogels, surface acoustic wave (SAW) electronic-nose sensors, as immunological (antibody), enzyme-linked immunosorbent assay (ELISA), enzymatic biosensor microbial biosensors, fiber optic biosensors, quartz crystal microbalance (QCM) and electromagnetic QCM (EQCM).

It is another object of the current invention to disclose the system as defined in any of the above, wherein the detector is configured to detect at least one environmental condition.